INTRODUCTION
The etiological agent of erythema chronicum migrans has been isolated and successfully propagated in the laboratory [1] [2] [3] [4] [5] . Studies completed or under way will tell us much about the metabolic requirements of the Lyme disease spirochete, its ultrastructure, its susceptibility to antimicrobial agents, and its genetic relatedness to other spirochetes. Nevertheless, we will probably still have much to learn of how this previously unknown spirochete causes the skin lesion, the meningoencephalitis, the cardiac abnormalities [6] , and, perhaps most difficult to understand, the arthritis of Lyme disease [7] . Although animal models of infection with this spirochete will be of value in revealing the pathogenesis of Lyme disease, studies of the immune response during human Lyme disease will provide complementary information. METHODS Techniques adapted from those of present-day basic biological research permit figurative dissection of the Lyme disease spirochete into components and identification of which components patients form antibody against. One of these techniques is the "western blot" (Fig. 1 schematically shows the western blot procedure). Cellular proteins and some non-proteinaceous components are first separated, according to their molecular weights, by sodium dodecyl sulfate-polyacrylamide gel electrophoresis [8] . The one-dimensionally separated components are then transferred electrophoretically from the gel to nitrocellulose, yielding a replica of the gel pattern on the nitrocellulose membrane matrix [9] . The unoccupied protein-binding sites on the membrane are then "blocked" with an excess of a globular protein such as bovine serum albumin. At this point, the "blot" is incubated with diluted antiserum or hybridoma culture supernatants, washed to remove unbound antibody, and then [10, 11] .
RESULTS
An early application of the western blot to the study of Lyme disease is shown in Fig. 2 . The patient, a resident of Shelter Island, NY (patient J.G. of [1] ), had erythema chronicum migrans, fever, myalgias, and malaise in June 1979. Blood was drawn and the serum was saved. In April 1980, a convalescent specimen was obtained and along with the acute illness serum was examined by western blot. Except for the dark bands seen in both acute and convalescent sera blots at the top in area of the stacking gel, only the convalescent serum showed evidence of having IgG antibodies that bound to spirochete components.
An expanded western blot study was then undertaken at Rocky Mountain Laboratories in collaboration with Drs. Allen Steere and Edgar Grunwaldt and with the help of several other investigators [11] . The results of this study showed that: (1) There are several Ixodes dammini or Lyme disease spirochete components to which [11] . The synovial fluid was examined by western blot for IgG antibodies to components of not only strain B3 1, a cloned and many-passaged laboratory strain [2] , but also to the original Shelter Island tick isolate (IDS; [1] ), from which B31 had been derived and which had been passaged only three times before harvest for the studies, and to strain HBl9 [12] isolated from the blood of a patient with Lyme disease [3] . The western blot patterns of this synovial fluid were, with the exception of differences in reactivities with a very high molecular weight component and some low molecular weight components, identical for the three isolates (Fig. 3) . The pattern obtained with serum from this patient was the same as that seen with synovial fluid (data not shown).
Notable in these blots are the reactions of antibodies not only with the ten components previously identified [11] (and now denoted by their apparent molecular weights) but also with an eleventh component with apparent molecular weight of 34 X 103 (34K). This was the same apparent molecular weight of an abundant protein identified in the Coomassie brilliant blue-stained gel. The 34K molecular weight protein was in the region of the gel which has demonstrated variability between different strains [12] . A closer look at this part of the gel is shown in Fig. 4 .
When the western blot patterns produced with sera from many Lyme disease patients were examined, however, I found that few sera had detectable antibodies to components in the 34K region ( Table 1 ). The sera used in this accounting were those reported in [11] and samples from additional patients in the United States or Europe. Each serum was drawn late in the course of or during convalescence from an illness that by clinical criteria [13] was definite or probable Lyme disease. All sera had indirect immunofluorescence titers aganist Lyme disease spirochetes of 1 to 80 or greater. In our laboratory, titers of 1 to 80 or greater were seldom found in sera from controls [1, 11; Barbour AG: unpublished observations].
When the sera were grouped with regard to continent of origin, six of 34 United (46) anid carboniic anhlydrase (30) is shiown ini detail. The origini of the seveni isolates was described ini [12] . Large arrows inidicate the regioni in the gel (arounid 34 x 103 daltonis) whiere variationi betweeni strainis hias beeni noted. Straini B31 ini this gel was ani earlier passage of the sam-e straini shiowni in Fig. 3 . The closed trianigle inidicates a proteini in straini 50-2 that was niot detected ini the othier isolates. The failure to find evidence in European sera of any patients with antibodies to a 34K region component or of more than a few patients with antibodies to some other components suggests that there may be differences in the distributions of various serotypes between Europe and North America. Whether an inhomogenous geographic distribution of serotypes in any way results in dissimilarities between ixodid tick-associated syndromes on each side of the Atlantic, for example, in the apparent lower frequency of arthritis in Europe [6, 14] , remains to be determined.
